Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer

Authors:

Abstract
No abstract available
Funding Information
  • Cilag (C11496/A30025)
  • Horizon 2020 Framework Programme (892360)
  • Wellcome Trust (FC0010218)
  • National Institute for Health and Care Research
  • Entertainment Industry Foundation
  • American Association for Cancer Research
  • University College London Hospitals Biomedical Research Centre
  • Melanoma Research Alliance
  • Royal Marsden Cancer Charity
  • Institute of Cancer Research (A109)
  • Royal Society (RP/EA/180007)
  • Cancer Research UK (C50947/A18176)
  • European Society for Medical Oncology
  • NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
  • Manchester Biomedical Research Centre
  • Royal Marsden NHS Foundation Trust (RMCC32)
  • Horizon 2020
  • Rosetrees Trust (M926)
  • Rosetrees Trust (A2204)
  • European Research Council (RP150154)
  • European Research Council (835297)
  • Novo Nordisk Fonden (ID16584)
  • Breast Cancer Research Foundation (BCRF 20-157)
  • Francis Crick Institute (FC001030)
  • Francis Crick Institute (FC001169)
  • Francis Crick Institute (FC001002)
  • Francis Crick Institute (FC001099)
  • Francis Crick Institute (FC001218)
  • Francis Crick Institute (FC011104)
  • Francis Crick Institute (FC001988)
  • Francis Crick Institute (FC001078)
  • UK Research and Innovation (203135)
  • UK Research and Innovation (222754)
  • UK Research and Innovation (MR/W005611/1)
  • National Institutes of Health
  • Medical Research Council

This publication has 29 references indexed in Scilit: